Global Equine Rabies Immunoglobulin (ERIG) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Equine Rabies Immunoglobulin (ERIG) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Equine Rabies Immunoglobulin (ERIG) by Country/Region, 2017, 2022 & 2028

2.2 Equine Rabies Immunoglobulin (ERIG) Segment by Type

2.2.1 1500IU

2.2.2 1000IU

2.2.3 400IU

2.2.4 Other

2.3 Equine Rabies Immunoglobulin (ERIG) Sales by Type

2.3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2022)

2.3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Type (2017-2022)

2.4 Equine Rabies Immunoglobulin (ERIG) Segment by Application

2.4.1 Category II Exposure

2.4.2 Category III Exposure

2.5 Equine Rabies Immunoglobulin (ERIG) Sales by Application

2.5.1 Global Equine Rabies Immunoglobulin (ERIG) Sale Market Share by Application (2017-2022)

2.5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Application (2017-2022)

3 Global Equine Rabies Immunoglobulin (ERIG) by Company

3.1 Global Equine Rabies Immunoglobulin (ERIG) Breakdown Data by Company

3.1.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales by Company (2020-2022)

3.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2020-2022)

3.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue by Company (2020-2022)

3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2020-2022)

3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2020-2022)

3.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Company

3.4 Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Location Distribution

3.4.2 Players Equine Rabies Immunoglobulin (ERIG) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Equine Rabies Immunoglobulin (ERIG) by Geographic Region

4.1 World Historic Equine Rabies Immunoglobulin (ERIG) Market Size by Geographic Region (2017-2022)

4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue by Geographic Region

4.2 World Historic Equine Rabies Immunoglobulin (ERIG) Market Size by Country/Region (2017-2022)

4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue by Country/Region

4.3 Americas Equine Rabies Immunoglobulin (ERIG) Sales Growth

4.4 APAC Equine Rabies Immunoglobulin (ERIG) Sales Growth

4.5 Europe Equine Rabies Immunoglobulin (ERIG) Sales Growth

4.6 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Growth

5 Americas

5.1 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Country

5.1.1 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022)

5.1.2 Americas Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022)

5.2 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Type

5.3 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Region

6.1.1 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022)

6.1.2 APAC Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022)

6.2 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Type

6.3 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Equine Rabies Immunoglobulin (ERIG) by Country

7.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022)

7.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022)

7.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type

7.3 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) by Country

8.1.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022)

8.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type

8.3 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Equine Rabies Immunoglobulin (ERIG)

10.3 Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)

10.4 Industry Chain Structure of Equine Rabies Immunoglobulin (ERIG)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Equine Rabies Immunoglobulin (ERIG) Distributors

11.3 Equine Rabies Immunoglobulin (ERIG) Customer

12 World Forecast Review for Equine Rabies Immunoglobulin (ERIG) by Geographic Region

12.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Region

12.1.1 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Region (2023-2028)

12.1.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Type

12.7 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Application

13 Key Players Analysis

13.1 Serum China

13.1.1 Serum China Company Information

13.1.2 Serum China Equine Rabies Immunoglobulin (ERIG) Product Offered

13.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Serum China Main Business Overview

13.1.5 Serum China Latest Developments

13.2 Lanzhou Institute of Biological Products

13.2.1 Lanzhou Institute of Biological Products Company Information

13.2.2 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Offered

13.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Lanzhou Institute of Biological Products Main Business Overview

13.2.5 Lanzhou Institute of Biological Products Latest Developments

13.3 Wuhan Institute of Biological Products

13.3.1 Wuhan Institute of Biological Products Company Information

13.3.2 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Offered

13.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Wuhan Institute of Biological Products Main Business Overview

13.3.5 Wuhan Institute of Biological Products Latest Developments

13.4 Premium Serums

13.4.1 Premium Serums Company Information

13.4.2 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Offered

13.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Premium Serums Main Business Overview

13.4.5 Premium Serums Latest Developments

13.5 Haffkine Bio-Pharmaceutical

13.5.1 Haffkine Bio-Pharmaceutical Company Information

13.5.2 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Offered

13.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Haffkine Bio-Pharmaceutical Main Business Overview

13.5.5 Haffkine Bio-Pharmaceutical Latest Developments

13.6 Bharat Serums

13.6.1 Bharat Serums Company Information

13.6.2 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Offered

13.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bharat Serums Main Business Overview

13.6.5 Bharat Serums Latest Developments

14 Research Findings and Conclusion

Table 1. Equine Rabies Immunoglobulin (ERIG) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Equine Rabies Immunoglobulin (ERIG) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 1500IU

Table 4. Major Players of 1000IU

Table 5. Major Players of 400IU

Table 6. Major Players of Other

Table 7. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)

Table 8. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2022)

Table 9. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & ($ million)

Table 10. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2022)

Table 11. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)

Table 13. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2022)

Table 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022)

Table 15. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2022)

Table 16. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Equine Rabies Immunoglobulin (ERIG) Sales by Company (2020-2022) & (K Units)

Table 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2020-2022)

Table 19. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2020-2022)

Table 21. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Producing Area Distribution and Sales Area

Table 23. Players Equine Rabies Immunoglobulin (ERIG) Products Offered

Table 24. Equine Rabies Immunoglobulin (ERIG) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Equine Rabies Immunoglobulin (ERIG) Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Geographic Region (2017-2022)

Table 29. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Equine Rabies Immunoglobulin (ERIG) Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country/Region (2017-2022)

Table 33. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (K Units)

Table 36. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2017-2022)

Table 37. Americas Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2017-2022)

Table 39. Americas Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)

Table 40. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2022)

Table 41. Americas Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)

Table 42. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2022)

Table 43. APAC Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022) & (K Units)

Table 44. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2017-2022)

Table 45. APAC Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2017-2022)

Table 47. APAC Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)

Table 48. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2022)

Table 49. APAC Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)

Table 50. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2022)

Table 51. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (K Units)

Table 52. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2017-2022)

Table 53. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2017-2022)

Table 55. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)

Table 56. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2022)

Table 57. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)

Table 58. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Equine Rabies Immunoglobulin (ERIG)

Table 68. Key Market Challenges & Risks of Equine Rabies Immunoglobulin (ERIG)

Table 69. Key Industry Trends of Equine Rabies Immunoglobulin (ERIG)

Table 70. Equine Rabies Immunoglobulin (ERIG) Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Equine Rabies Immunoglobulin (ERIG) Distributors List

Table 73. Equine Rabies Immunoglobulin (ERIG) Customer List

Table 74. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Forecast by Region

Table 76. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Application (2023-2028)

Table 94. Serum China Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors

Table 95. Serum China Equine Rabies Immunoglobulin (ERIG) Product Offered

Table 96. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Serum China Main Business

Table 98. Serum China Latest Developments

Table 99. Lanzhou Institute of Biological Products Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors

Table 100. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Offered

Table 101. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Lanzhou Institute of Biological Products Main Business

Table 103. Lanzhou Institute of Biological Products Latest Developments

Table 104. Wuhan Institute of Biological Products Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors

Table 105. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Offered

Table 106. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Wuhan Institute of Biological Products Main Business

Table 108. Wuhan Institute of Biological Products Latest Developments

Table 109. Premium Serums Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors

Table 110. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Offered

Table 111. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Premium Serums Main Business

Table 113. Premium Serums Latest Developments

Table 114. Haffkine Bio-Pharmaceutical Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors

Table 115. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Offered

Table 116. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Haffkine Bio-Pharmaceutical Main Business

Table 118. Haffkine Bio-Pharmaceutical Latest Developments

Table 119. Bharat Serums Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors

Table 120. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Offered

Table 121. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Bharat Serums Main Business

Table 123. Bharat Serums Latest Developments

List of Figures

Figure 1. Picture of Equine Rabies Immunoglobulin (ERIG)

Figure 2. Equine Rabies Immunoglobulin (ERIG) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Equine Rabies Immunoglobulin (ERIG) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 1500IU

Figure 10. Product Picture of 1000IU

Figure 11. Product Picture of 400IU

Figure 12. Product Picture of Other

Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type in 2021

Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2022)

Figure 15. Equine Rabies Immunoglobulin (ERIG) Consumed in Category II Exposure

Figure 16. Global Equine Rabies Immunoglobulin (ERIG) Market: Category II Exposure (2017-2022) & (K Units)

Figure 17. Equine Rabies Immunoglobulin (ERIG) Consumed in Category III Exposure

Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Market: Category III Exposure (2017-2022) & (K Units)

Figure 19. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2022)

Figure 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application in 2021

Figure 21. Equine Rabies Immunoglobulin (ERIG) Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company in 2021

Figure 23. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Geographic Region in 2021

Figure 25. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2017-2022)

Figure 26. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country/Region in 2021

Figure 27. Americas Equine Rabies Immunoglobulin (ERIG) Sales 2017-2022 (K Units)

Figure 28. Americas Equine Rabies Immunoglobulin (ERIG) Revenue 2017-2022 ($ Millions)

Figure 29. APAC Equine Rabies Immunoglobulin (ERIG) Sales 2017-2022 (K Units)

Figure 30. APAC Equine Rabies Immunoglobulin (ERIG) Revenue 2017-2022 ($ Millions)

Figure 31. Europe Equine Rabies Immunoglobulin (ERIG) Sales 2017-2022 (K Units)

Figure 32. Europe Equine Rabies Immunoglobulin (ERIG) Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue 2017-2022 ($ Millions)

Figure 35. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2021

Figure 36. Americas Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2021

Figure 37. United States Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2021

Figure 42. APAC Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Regions in 2021

Figure 43. China Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2021

Figure 50. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2021

Figure 51. Germany Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2021

Figure 58. Egypt Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Equine Rabies Immunoglobulin (ERIG) in 2021

Figure 64. Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)

Figure 65. Industry Chain Structure of Equine Rabies Immunoglobulin (ERIG)

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles